Compare · GRPH vs MEHA

GRPH vs MEHA

Side-by-side comparison of Graphite Bio Inc. (GRPH) and Functional Brands Inc. (MEHA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both GRPH and MEHA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • GRPH has more recent analyst coverage (16 ratings vs 0 for MEHA).
MetricGRPHMEHA
Company
Graphite Bio Inc.
Functional Brands Inc.
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NASDAQ
IPO
2021
News (4w)
0
0
Recent ratings
16
0
GRPH

Graphite Bio Inc.

Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression; GPH201 for the treatment of X-linked severe combined immunodeficiency syndrome; and GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Latest GRPH

Latest MEHA